Literature DB >> 27882423

Cardio-Ankle Vascular Index (CAVI) and Plasma Transforming Growth Factor-β1 (TGF-β1) Level Correlate with Aortopathy in Adults with Repaired Tetralogy of Fallot.

Yumi Shiina1, Koichiro Niwa2.   

Abstract

It is challenging to evaluate aortopathy in congenital heart disease using conventional investigations such as brachial-ankle pulse wave velocity (baPWV). Therefore, we evaluated the cardio-ankle vascular index (CAVI), a dimension of the ascending aorta and plasma transforming growth factor-β1 (TGF-β1) level, in order to find novel noninvasive parameters of aortopathy in adults with repaired tetralogy of Fallot (TOF). Prospectively, we enrolled 42 consecutive adults with TOF (28 patients with repaired TOF were not on ARB, 8 patients with repaired TOF on ARB, 6 patients with no repair or only palliative repair) and 20 age-matched healthy controls. We measured CAVI, baPWV, plasma TGF-β1 level and a diameter of the ascending aorta using echocardiography. The mean age of repaired TOF without ARB were 31.9 ± 9.1 years. An aortic diameter of the ascending aorta, CAVI, and plasma TGF-β1 level were significantly higher in repaired TOF without ARB than those in controls, whereas baPWV did not differ. On a univariate analysis, CAVI, plasma TGF-β1 level and Rastelli procedure were important factors for an aortic diameter of the ascending aorta (r = 0.56, P < 0.01, r = 0.59, P < 0.01, r = 0.39, P < 0.05, respectively) in this population. There was no significant correlation with age, baPWV, NT-pro brain natriuretic peptide (BNP), repair age, shunt duration, aortic regurgitation or right aortic arch. On the other hand, patients with unrepaired or palliative TOF, who had obvious volume overload, showed no significant correlation with CAVI, baPWV or plasma TGF-β1 level. CAVI and plasma TGF-β1 level, not baPWV, correlate to aortopathy in adults with repaired TOF.

Entities:  

Keywords:  Aortopathy; CAVI; Congenital heart disease; TGF-β; Tetralogy of Fallot; baPWV

Mesh:

Substances:

Year:  2016        PMID: 27882423     DOI: 10.1007/s00246-016-1519-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  16 in total

1.  Circulating transforming growth factor-beta in Marfan syndrome.

Authors:  Peter Matt; Florian Schoenhoff; Jennifer Habashi; Tammy Holm; Christel Van Erp; David Loch; Olga D Carlson; Benjamin F Griswold; Qin Fu; Julie De Backer; Bart Loeys; David L Huso; Nazli B McDonnell; Jennifer E Van Eyk; Harry C Dietz
Journal:  Circulation       Date:  2009-07-27       Impact factor: 29.690

Review 2.  Aortic root dilatation in tetralogy of Fallot long-term after repair--histology of the aorta in tetralogy of Fallot: evidence of intrinsic aortopathy.

Authors:  Koichiro Niwa
Journal:  Int J Cardiol       Date:  2005-08-18       Impact factor: 4.164

3.  Hypoxia-Inducible Factor-1α Activates the Transforming Growth Factor-β/SMAD3 Pathway in Kidney Tubular Epithelial Cells.

Authors:  Natsuki Kushida; Seitaro Nomura; Imari Mimura; Takanori Fujita; Shogo Yamamoto; Masaomi Nangaku; Hiroyuki Aburatani
Journal:  Am J Nephrol       Date:  2016-09-09       Impact factor: 3.754

4.  Aneurysm development in patients with a bicuspid aortic valve is not associated with transforming growth factor-β activation.

Authors:  Valentina Paloschi; Jesper R Gådin; Shaukat Khan; Hanna M Björck; Lei Du; Shohreh Maleki; Joy Roy; Jan H M Lindeman; Salah A Mohamed; Takeshi Tsuda; Anders Franco-Cereceda; Per Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

5.  Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.

Authors:  Maria Nataatmadja; Jennifer West; Malcolm West
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

Review 6.  Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives.

Authors:  Kohji Shirai; Noriyuki Hiruta; Mingquiang Song; Takumi Kurosu; Jun Suzuki; Takanobu Tomaru; Yoh Miyashita; Atsuto Saiki; Mao Takahashi; Kenji Suzuki; Masanobu Takata
Journal:  J Atheroscler Thromb       Date:  2011-05-31       Impact factor: 4.928

7.  Aortic stiffness and aortic dilation in infants and children with tetralogy of Fallot before corrective surgery: evidence for intrinsically abnormal aortic mechanical property.

Authors:  Mitsuru Seki; Clara Kurishima; Hidenori Kawasaki; Satoshi Masutani; Hideaki Senzaki
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-12       Impact factor: 4.191

8.  Aortic surgery is one of the risk factors for enhancement of pressure wave reflection in adult patients with congenital heart disease.

Authors:  Tomoaki Murakami; Shigeru Tateno; Yasutaka Kawasoe; Koichiro Niwa
Journal:  Int J Cardiol       Date:  2014-06-27       Impact factor: 4.164

9.  Genetic determinants of right-ventricular remodeling after tetralogy of Fallot repair.

Authors:  Aamir Jeewa; Ashok Kumar Manickaraj; Luc Mertens; Cedric Manlhiot; Caroline Kinnear; Tapas Mondal; John Smythe; Herschel Rosenberg; Jane Lougheed; Brian W McCrindle; Glen van Arsdell; Andrew N Redington; Seema Mital
Journal:  Pediatr Res       Date:  2012-07-13       Impact factor: 3.756

10.  Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: a case series report.

Authors:  Manuel Ángel Gómez-Marcos; José Ignacio Recio-Rodríguez; María Carmen Patino-Alonso; Cristina Agudo-Conde; Leticia Gómez-Sánchez; Marta Gomez-Sanchez; Emiliano Rodríguez-Sanchez; Jose Angel Maderuelo-Fernandez; Luís García-Ortiz
Journal:  Cardiovasc Diabetol       Date:  2015-01-16       Impact factor: 9.951

View more
  1 in total

Review 1.  The Predictive Role of Plasma Biomarkers in the Evolution of Aortopathies Associated with Congenital Heart Malformations.

Authors:  Amalia Făgărășan; Maria Oana Săsăran
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.